Stay Updated with the Latest First Trust AlphaDEX U.S. Technology Sector Index ETF FHQ.TO News in Real Time
Find FHQ.TO news now at Meyka AI. Stay informed with the latest First Trust AlphaDEX U.S. Technology Sector Index ETF stocks updates, including price news, market analysis, and expert insights.
Social Security Benefits Face 22% Cut by 2032 Without Congressional Action
Social Security trust fund projected to deplete by 2032, triggering a 22% automatic benefit cut unless Congress passes reform. Three main proposals being debated.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Bitcoin Jumps 6.4% to $77,699 as Volatility-Adjusted Rally Signals Regime Shift
Bitcoin surges 6.4% to $77,699 in a volatility-adjusted move analysts compare to the fifth-largest since 2018, signaling a potential bull market inflection.
Lido Staked ETH USD Rallies 5.9% to $2,462 as Momentum Indicators Flash Overbought
STETHUSD jumped 5.9% to $2,462.17 in 24 hours with RSI at 83.88 and price above Bollinger upper band, signaling extreme overbought conditions.
Taylor Sheridan Sued by Writer Over Yellowstone Copyright Claim, August 24
Writer Lauren J. Salkin sues Taylor Sheridan, claiming he stole Yellowstone from her 2016 Sovereign Nation pitch. Lawsuit seeks injunction and damages including profits from the hit series.
Ethereum Surges 5.9% to $2,464.69 as RSI Hits Extreme Overbought 84.7
Ethereum USD jumped 5.9% to $2,464.69 in 24 hours with RSI at 84.7, signaling extreme overbought conditions and a potential pullback.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Zcash Surges 49.2% to $847.56 as RSI Hits Extreme Overbought 77.9
Zcash USD jumped 49.2% to $847.56 in 24 hours with RSI at 77.9 and volume 2.26x average, signaling extreme overbought conditions.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.